Phase III multicenter study in epithelial ovarian carcinoma FIGO stage IIb-IV comparing treatment with paclitaxel and carboplatin to paclitaxel and carboplatin sequentially followed by topotecan

Trial Profile

Phase III multicenter study in epithelial ovarian carcinoma FIGO stage IIb-IV comparing treatment with paclitaxel and carboplatin to paclitaxel and carboplatin sequentially followed by topotecan

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Topotecan (Primary) ; Carboplatin; Paclitaxel
  • Indications Carcinoma; Fallopian tube cancer; Ovarian cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2017 Results (n=4578) of validation of prognostic value of KELIM regarding PFS and OS in phase 3 trial (AGO-OVAR 9, AGO-OVAR 7, ICON 7) datasets presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 24 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top